FILE - The Pfizer logo is displayed at the company's headquarters, Friday, Feb. 5, 2021, in New York. A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the ...

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it posted its third-quarter earnings report. During the call, the pharma ...